Cargando…
Varicella vaccination in Europe – taking the practical approach
Varicella is a common viral disease affecting almost the entire birth cohort. Although usually self-limiting, some cases of varicella can be serious, with 2 to 6% of cases attending a general practice resulting in complications. The hospitalisation rate for varicella in Europe ranges from 1.3 to 4.5...
Autores principales: | Bonanni, Paolo, Breuer, Judith, Gershon, Anne, Gershon, Michael, Hryniewicz, Waleria, Papaevangelou, Vana, Rentier, Bernard, Rümke, Hans, Sadzot-Delvaux, Catherine, Senterre, Jacques, Weil-Olivier, Catherine, Wutzler, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697173/ https://www.ncbi.nlm.nih.gov/pubmed/19476611 http://dx.doi.org/10.1186/1741-7015-7-26 |
Ejemplares similares
-
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019) -
The Varicella-Zoster Virus Immediate-Early 63 protein affects chromatin controlled gene transcription in a cell-type dependent manner
por: Habran, Lionel, et al.
Publicado: (2007) -
Varicella-Zoster Virus IE4 Protein Interacts with SR Proteins and Exports mRNAs through the TAP/NXF1 Pathway
por: Ote, Isabelle, et al.
Publicado: (2009) -
The Varicella-Zoster Virus ORF47 Kinase Interferes with Host Innate Immune Response by Inhibiting the Activation of IRF3
por: Vandevenne, Patricia, et al.
Publicado: (2011) -
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)